- cafead Mar 30, 2023 at 11:13: AM
via Drug price negotiation is the boogeyman awaiting Big Pharma in 2026. So, which medicines will be subject to the U.S. government’s newfound ability to broker prices—the most impactful measure from last year’s Inflation Reduction Act?
article source
article source